February 4, 2009 (Bloomington, Indiana) - A new personal health assessment could prove to be the difference between good health and heart disease for many people. TheViveda Cardio Assessment, recently ...

The 10-year risk estimates for major adverse cardiovascular events underestimate the 20-year cardiovascular burden by nearly three- to tenfold, with the increase in events between 10 and 20 years ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD ...

On Average, 41% More Sensitive Than Current Tests for Predicting Future Heart Disease in Women CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease ...

A recent study indicates that an AI tool can analyze routine mammogram scans for breast cancer screening and predict heart disease risk in women.

Withings has shared an early look at its upcoming health device and the company says it’s the “most precise and complete smart scale” and also comes with “its first advanced services offer.” The Body ...

Cardio Diagnostics’ PrecisionCHD™ test is an AI-powered integrated genetic-epigenetic test to aid in the diagnosis and management of CHD. The six DNA methylation markers evaluated by the PrecisionCHD™ ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk assessments used in the general population did not accurately predict risk among men with ...

Apple has revamped its Apple Watch health metrics, with its all-new cardio fitness notifications. The feature has launched as part of watchOS 7.2, and will track users’ cardio fitness – based on VO2 ...